Bora CDMO Bora CDMO

X

Find Nisoxetine manufacturers, exporters & distributors on PharmaCompass

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

0

US DMFs Filed

US DMFs Filed

0

CEP/COS Certifications

CEP/COS Certifications

0

JDMFs Filed

JDMFs Filed

0

Other Certificates

Other Certificates

0

Other Suppliers

Other Suppliers

0

API REF. PRICE (USD / KG)

0

INTERMEDIATES

0

DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Uploaded Dossiers

Uploaded Dossiers

0

GLOBAL SALES (USD Million)

U.S. Medicaid

0

Annual Reports

0

EXCIPIENTS

0

PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

0

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

0

News

0

REF STANDARD

EDQM

0

USP

0

JP

0

Other Listed Suppliers

0

SERVICES

0

Prestwick3_000910
Also known as: 53179-07-0, 3-(2-methoxyphenoxy)-n-methyl-3-phenylpropan-1-amine, Compound 89218, 3-(2-methoxyphenoxy)-n-methyl-3-phenylpropylamine, 57226-61-6, Dl-n-methyl-3-(o-methoxyphenoxy)-n-methyl-3-phenylpropylamine
Molecular Formula
C17H21NO2
Molecular Weight
271.35  g/mol
InChI Key
ITJNARMNRKSWTA-UHFFFAOYSA-N
FDA UNII
17NV064B2D

Nisoxetine is a selective norepinephrine reuptake inhibitor (SNRI) developed in the 1970s. It was originally investigated as an antidepressant but has no current clinical applications aside from being a research standard SNRI. It has been used to research obesity and energy balance, and exerts some local analgesia effects.
1 2D Structure

Prestwick3_000910

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
3-(2-methoxyphenoxy)-N-methyl-3-phenylpropan-1-amine
2.1.2 InChI
InChI=1S/C17H21NO2/c1-18-13-12-15(14-8-4-3-5-9-14)20-17-11-7-6-10-16(17)19-2/h3-11,15,18H,12-13H2,1-2H3
2.1.3 InChI Key
ITJNARMNRKSWTA-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CNCCC(C1=CC=CC=C1)OC2=CC=CC=C2OC
2.2 Other Identifiers
2.2.1 UNII
17NV064B2D
2.3 Synonyms
2.3.1 MeSH Synonyms

1. 3-(2-methoxyphenoxy)-n-methyl-3-phenylpropylamine

2. 3-(o-methoxyphenoxy)-n-methyl-3-phenylpropylamine

3. Dl-n-methyl-3-(o-methoxyphenoxy)-n-methyl-3-phenylpropylamine

4. Lilly 135252

5. Lilly 94939

6. Ly 135252

7. Ly 94939

8. Ly-135252

9. N-methyl-gamma-(2-methylphenoxy)phenylpropanolamine

10. Nisoxetine Hydrochloride

11. Nisoxetine Hydrochloride, (+-)-isomer

12. Nisoxetine, (+-)-isomer

2.3.2 Depositor-Supplied Synonyms

1. 53179-07-0

2. 3-(2-methoxyphenoxy)-n-methyl-3-phenylpropan-1-amine

3. Compound 89218

4. 3-(2-methoxyphenoxy)-n-methyl-3-phenylpropylamine

5. 57226-61-6

6. Dl-n-methyl-3-(o-methoxyphenoxy)-n-methyl-3-phenylpropylamine

7. Nsc-283481

8. 3-(o-methoxyphenoxy)-n-methyl-3-phenylpropylamine

9. N-methyl-gamma-(2-methylphenoxy)phenylpropanolamine

10. Chembl295467

11. Chebi:73410

12. 17nv064b2d

13. Benzenepropanamine, Gamma-(2-methoxyphenoxy)-n-methyl-

14. Compound 89218; Nsc 283481

15. Ncgc00015715-04

16. Nisoxetine Inhibitor

17. Dsstox_cid_25175

18. Dsstox_rid_80724

19. Dsstox_gsid_45175

20. Nisoxetina

21. Nisoxetinum

22. Nisoxetine [usan:inn]

23. Cas-53179-07-0

24. Ly-94939

25. Unii-17nv064b2d

26. Nsc 283481

27. Ly 94939

28. Nisoxetine [inn]

29. Antioxidant1425

30. Nisoxetine (usan/inn)

31. Prestwick0_000910

32. Prestwick1_000910

33. Prestwick2_000910

34. Prestwick3_000910

35. Nisoxetine [usan]

36. Lopac0_000901

37. Bspbio_000760

38. Compound-89218

39. Schembl124289

40. Spbio_002959

41. Bpbio1_000836

42. Gtpl4637

43. Dtxsid0045175

44. Bdbm22417

45. Hms2089k13

46. Tox21 110203

47. Tox21_110203

48. Nsc283481

49. Pdsp1_000507

50. Pdsp2_000505

51. Tox21_110203_1

52. Ccg-204983

53. Db09186

54. Sdccgsbi-0050876.p002

55. Ncgc00015715-03

56. Ncgc00015715-05

57. Ncgc00015715-06

58. Ncgc00015715-08

59. Ncgc00015715-15

60. Ncgc00024945-02

61. Ncgc00024945-03

62. As-16468

63. Ab00514644

64. D05173

65. Ab00514644-07

66. N-methyl 3(o-methoxyphenoxy)-3-phenylpropylamine

67. N-methyl 3-(o-methoxyphenoxy)-3-phenylpropylamine

68. Q906885

69. [3-(2-methoxyphenoxy)-3-phenylpropyl](methyl)amine

70. N-methyl-3-phenyl-3-(o-methoxyphenoxy)-propylamine

71. Brd-a95696066-003-03-9

72. Brd-a95696066-003-06-2

73. (+/-)-3-(o-methoxyphenoxy)-n-methyl-3-phenylpropylamine

74. Benzenepropanamine, .gamma.-(2-methoxyphenoxy)-n-methyl-, (+/-)-

2.4 Create Date
2005-03-25
3 Chemical and Physical Properties
Molecular Weight 271.35 g/mol
Molecular Formula C17H21NO2
XLogP33.1
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count3
Rotatable Bond Count7
Exact Mass271.157228913 g/mol
Monoisotopic Mass271.157228913 g/mol
Topological Polar Surface Area30.5 Ų
Heavy Atom Count20
Formal Charge0
Complexity253
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count1
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY